BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14592832)

  • 21. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
    Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
    Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary diffuse large B cell lymphoma of the stomach: analysis of somatic mutations in the rearranged immunoglobulin heavy chain variable genes indicates antigen selection.
    Driessen A; Tierens A; Ectors N; Stul M; Pittaluga S; Geboes K; Delabie J; De Wolf-Peeters C
    Leukemia; 1999 Jul; 13(7):1085-92. PubMed ID: 10400425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma.
    Do B; Lossos IS; Thorstenson Y; Oefner PJ; Levy R
    Leuk Lymphoma; 2003 Aug; 44(8):1317-23. PubMed ID: 12952224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.
    Vater I; Montesinos-Rongen M; Schlesner M; Haake A; Purschke F; Sprute R; Mettenmeyer N; Nazzal I; Nagel I; Gutwein J; Richter J; Buchhalter I; Russell RB; Wiestler OD; Eils R; Deckert M; Siebert R
    Leukemia; 2015 Mar; 29(3):677-85. PubMed ID: 25189415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G-rich proto-oncogenes are targeted for genomic instability in B-cell lymphomas.
    Duquette ML; Huber MD; Maizels N
    Cancer Res; 2007 Mar; 67(6):2586-94. PubMed ID: 17363577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-6 gene hypermutations in diffuse large B-cell lymphoma of primary gastric origin.
    Liang R; Chan WP; Kwong YL; Chan AC; Xu WS; Au WY; Srivastava G; Ho FC
    Br J Haematol; 1997 Dec; 99(3):668-70. PubMed ID: 9401082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
    Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
    Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristic chromosomal imbalances in primary central nervous system lymphomas of the diffuse large B-cell type.
    Weber T; Weber RG; Kaulich K; Actor B; Meyer-Puttlitz B; Lampel S; Büschges R; Weigel R; Deckert-Schlüter M; Schmiedek P; Reifenberger G; Lichter P
    Brain Pathol; 2000 Jan; 10(1):73-84. PubMed ID: 10668897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
    Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
    [No Abstract]   [Full Text] [Related]  

  • 31. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
    Ueda C; Nishikori M; Kitawaki T; Uchiyama T; Ohno H
    Int J Hematol; 2004 Jan; 79(1):52-4. PubMed ID: 14979479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant somatic hypermutations in thyroid lymphomas.
    Takakuwa T; Miyauchi A; Aozasa K
    Leuk Res; 2009 May; 33(5):649-54. PubMed ID: 19019431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas.
    Bertoni F; Conconi A; Luminari S; Realini C; Roggero E; Baldini L; Carobbio S; Cavalli F; Neri A; Zucca E
    Leukemia; 2000 Mar; 14(3):446-8. PubMed ID: 10720140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.
    Nakamura T; Tateishi K; Niwa T; Matsushita Y; Tamura K; Kinoshita M; Tanaka K; Fukushima S; Takami H; Arita H; Kubo A; Shuto T; Ohno M; Miyakita Y; Kocialkowski S; Sasayama T; Hashimoto N; Maehara T; Shibui S; Ushijima T; Kawahara N; Narita Y; Ichimura K
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):279-90. PubMed ID: 26111727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
    Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
    Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis of primary central nervous system lymphoma.
    Bruno A; Boisselier B; Labreche K; Marie Y; Polivka M; Jouvet A; Adam C; Figarella-Branger D; Miquel C; Eimer S; Houillier C; Soussain C; Mokhtari K; Daveau R; Hoang-Xuan K
    Oncotarget; 2014 Jul; 5(13):5065-75. PubMed ID: 24970810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
    Rossi D; Gaidano G
    Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.